fda news - Search News

FDA Approves 1st New Schizophrenia Drug in Decades

FDA Approves New Kind of Drug for Schizophrenia

FRIDAY, Sept. 27, 2024 (HealthDay News) -- The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and Drug Administration.

The Washington Post on MSN · 18h

FDA approves new type of antipsychotic drug, a potential ‘game changer’

The approval comes less than a year Bristol Myers Squibb paid $14 billion to acquire the developer of the drug, Karuna Therapeutics.

Time on MSN · 3h

FDA Approves the First New Schizophrenia Drug in Decades

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric disorder.

Sanofi, FDA and Dupixent

Hosted on MSN · 1h

Sanofi-Regeneron's Dupixent wins FDA's nod for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a chronic lung disease, commonly known as "smoker's lung", the companies said on Friday.

The Wall Street Journal on MSN · 2h

Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD

Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.

Detroit News · 1h

Sanofi blockbuster drug wins clearance in US for lung disease

Sanofi’s Dupixent has been cleared for a chronic lung disorder in the US, in another milestone for the blockbuster drug after a similar decision by European regulators.

Pfizer, FDA and Oxbryta

Hosted on MSN · 10h

FDA alerts patients about Pfizer's Oxbryta withdrawal

The U.S. Food and Drug Administration on Thursday alerted patients and healthcare professionals about the withdrawal of Pfizer's sickle cell disease treatment Oxbryta. Pfizer said late on Wednesday it was pulling the drug from all markets due to risk of a painful complication and death.

STAT · 21h

What the withdrawal of its sickle cell drug means for Pfizer, patients, and the FDA

European regulators on Thursday also said that patients in the trials had higher rates of the pain crises that are hallmarks of sickle cell disease once they started on Oxbryta, also called voxelotor,

Wall Street Journal · 1d

Pfizer to Withdraw Sickle Cell Drug Oxbryta Lots from World-Wide Markets

The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the approved sickle cell patient population.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 22h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 21h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 22h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

MedPage Today1h

COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says

The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...

FDA Approves Potentially Groundbreaking Schizophrenia Drug

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

18h

FDA approves 1st new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

21h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

23h

FDA’s views on AI are evolving

The guidance is based in part on responses the agency received to a 2023 discussion paper on the topic. The paper received ...

16h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

FDA Warns Recalled Dog Food Should Be 'Thrown Out or Destroyed'

The pet food was found to be contaminated with bacteria that can cause illness and even death in pets and humans.

FDA approves new type of schizophrenia drug

The U.S. Food and Drug Administration (FDA) on Friday approved a new drug used for treating schizophrenia in adults, ...

Medscape2h

FDA OKs First-in-Class Antipsychotic for Schizophrenia

The FDA has approved a first-in-class antipsychotic that targets cholinergic receptors without blocking dopamine receptors.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics